J D Schlaifer

University of Florida, Gainesville, FL, United States

Are you J D Schlaifer?

Claim your profile

Publications (10)21.76 Total impact

  • [Show abstract] [Hide abstract]
    ABSTRACT: This study examined whether the adenosine receptor antagonist theophylline prevents the warm-up phenomenon in patients with stable angina undergoing serial exercise tests. Our findings offer evidence that adenosine does not play a role in the warm-up phenomenon, and indirectly suggest that the warm-up phenomenon does not represent ischemic preconditioning in humans.
    The American Journal of Cardiology 12/1999; 84(9):1077-80, A9. · 3.21 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Our study evaluated the influence of smoking status on coronary endothelial function in normotensive patients with coronary artery disease who received placebo or the angiotensin-converting enzyme inhibitor quinapril in the TREND study (Trial on Reversing Endothelial Dysfunction). In this retrospective analysis of data from the previously published study, patients were classified as either smokers (n = 23) or nonsmokers (n = 82). Patients underwent coronary angiography at baseline and again after 6-month follow-up. The primary response variable was the net change in acetylcholine-induced diameter of the target coronary artery segments (n = 105) between the baseline and 6-month follow-up angiograms. The secondary response variables were based on analysis of all segments (n = 300) and the mean diameter responses of target and all segments at 6 months. At baseline, coronary artery vasomotor responses were similar in smokers and nonsmokers in the placebo and quinapril groups. There was a significant improvement in the primary response variable for both smokers (P = 0.008) and nonsmokers (P = 0.047) randomized to quinapril compared with placebo. At 6-month follow-up, nonsmokers in the placebo group showed no significant change in the mean vasoconstrictor responses (8.3% vs. 8.0% at acetylcholine 10(-4) mol/L), whereas nonsmokers in the quinapril-treated group showed significantly less vasoconstriction (2.7% vs. 13.2%; P = 0.003). Among smokers in the placebo group, vasoconstriction increased nonsignificantly (21.7% vs. 17.2% at baseline) but decreased significantly in the quinapril group (0.5% vs. 17.9%; P = 0.002). These results indicate that ACE inhibition improves the coronary vasomotor response in both smokers and nonsmokers, but that smokers apparently derive greater benefit.
    Cardiovascular Drugs and Therapy 06/1999; 13(3):201-9. · 2.67 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Summary. Our study evaluated the influence of smoking status on coronary endothelial function in normotensive patients with coronary artery disease who received placebo or the angiotensin-converting enzyme inhibitor quinapril in the TREND study (Trial on Reversing Endothelial Dysfunction). In this retrospective analysis of data from the previously published study, patients were classified as either smokers (n = 23) or nonsmokers (n = 82). Patients underwent coronary angiography at baseline and again after 6 months follow-up. The primary response variable was the net change in acetylcholine-induced diameter of the target coronary artery segments (n = 105) between the baseline and 6-month follow-up angiograms. The secondary response variables were based on analysis of all segments (n = 300) and the mean diameter responses of target and all segments at 6 months. At baseline, coronary artery vasomotor responses were similar in smokers and nonsmokers in the placebo and quinapril groups. There was a significant improvement in the primary response variable for both smokers (P = 0.008) and nonsmokers (P = 0.047) randomized to quinapril compared with placebo. At 6 months follow-up, nonsmokers in the placebo group showed no significant change in the mean vasoconstrictor responses (8.3% vs. 8.0% at acetylcholine 10 -4 mol/L), whereas nonsmokers in the quinapril-treated group showed significantly less vasoconstriction (2.7% vs. 13.2%; P = 0.003). Among smokers in the placebo group, vasoconstriction increased nonsignificantly (21.7% vs. 17.2% at baseline) but decreased significantly in the quinapril group (0.5% vs. 17.9%; P = 0.002). These results indicate that ACE inhibition improves the coronary vasomotor response in both smokers and nonsmokers, but that smokers apparently derive greater benefit. Peer Reviewed http://deepblue.lib.umich.edu/bitstream/2027.42/44562/1/10557_2004_Article_203634.pdf
    Cardiovascular Drugs and Therapy 01/1999; · 2.67 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Cigarette smoking is a major risk factor for developing coronary artery disease and is associated with increased coronary morbidity and mortality in patients with established atherosclerosis. This report describes the influence of smoking on coronary endothelial function in normotensive patients with coronary artery disease, but without left ventricular dysfunction, severe hypercholesterolemia, or insulin-dependent diabetes mellitus. Placebo-treated patients (n = 54) from a larger study assessing coronary endothelial function were classified at baseline as smokers or nonsmokers for this subgroup analysis. Patients underwent coronary angiography at baseline and again after 6-month follow-up. At baseline, there was a trend for a greater decrease in target segment diameter (n = 54) in smokers compared with nonsmokers (-17.2 +/- 5.3% vs. -8.0 +/- 2.5%, acetylcholine 10(-4) mol/l). All measured coronary artery segments (n = 202) showed similar responses (-7.3 +/- 2.7% vs. -3.8 +/- 1.3%, acetylcholine 10(-4) mmol/l, for smokers vs. nonsmokers, respectively). After 6 months, smokers showed an even greater vasoconstrictor response to acetylcholine whereas nonsmokers did not (-21.7 +/- 5.3% vs. -8.3 +/- 2.5%, acetylcholine 10(-4) mmol/l). The vasodilatory response to nitroglycerin was similar in smokers and nonsmokers. In current smokers, a marked decline in endothelium-dependent vasomotor response was observed over a 6-month period.
    Clinical Cardiology 06/1998; 21(5):331-4. · 1.83 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: This pilot study evaluates the effects of quinapril, an angiotensin-converting enzyme inhibitor with high tissue-binding affinity, on microvascular endothelial function in patients with mild (<40% narrowing) coronary artery disease and epicardial endothelial dysfunction. Patients randomized to quinapril had a trend suggesting an increase in endothelium-dependent coronary blood flow response.
    The American Journal of Cardiology 12/1997; 80(12):1594-7. · 3.21 Impact Factor
  • Source
    J D Schlaifer, R A Kerensky
    [Show abstract] [Hide abstract]
    ABSTRACT: Experimental animal studies have shown that repetitive brief coronary occlusions render the heart resistant to myocardial infarction from subsequent, more prolonged, coronary occlusions. This phenomenon in animal models has been called ischemic preconditioning. In a number of clinical scenarios, the second in a series of ischemic episodes appears to be less severe than the first, suggesting that ischemic preconditioning also occurs in humans. If the mediator of preconditioning could be identified, it is conceivable that this agent could be administered to patients with coronary artery disease as a myocardial protectant. However, the definite clinical relevance of this interesting experimental finding remains unknown. Unlike the case in animal models subjected to an abrupt occlusion, preconditioning is difficult to study in the clinical setting. This article reviews the findings and limitations of the relevant clinical studies looking for ischemic preconditioning in humans.
    Clinical Cardiology 08/1997; 20(7):602-6. · 1.83 Impact Factor
  • American Journal of Cardiology - AMER J CARDIOL. 01/1997; 80(12):1594-1597.
  • J D Schlaifer, J A Hill
    [Show abstract] [Hide abstract]
    ABSTRACT: Guidewires can distort a tortuous vessel, creating the illusion of an intraluminal defect that does not exist. This case report demonstrates the changing severity of defects in the same vessel seen with two different types of guidewires varying in stiffness.
    Catheterization and Cardiovascular Diagnosis 12/1996; 39(3):281-3.
  • J D Schlaifer, J A Hill
    [Show abstract] [Hide abstract]
    ABSTRACT: It is important to define both anatomic and functional significance of coronary artery stenoses. Quantitative angiography has decreased the inter- and intraobserver variability in interpreting the coronary angiogram, but it is less clinically applicable in assessing functional significance. The coronary Doppler catheter and guidewire can provide considerable information regarding the functional effects and pathophysiology of coronary stenosis in humans at the time of cardiac catheterization. Clinically, it is a simple and safe technique which makes it feasible in a clinical setting to use it as a tool to assess the physiologic significance of an intermediate stenosis or the functional result of an interventional procedure. Other uses for the intravascular Doppler method, such as the evaluation of cardiac transplant vasculopathy and rejection and evaluation of patients with chest pain syndromes and normal coronary angiograms, are being studied. However, the usefulness of this technique in decision-making has yet to be fully clarified. Future clinical studies should be directed toward comparing this method with noninvasive methods, that is, exercise treadmill test and thallium studies, and attempt to answer questions regarding its prognostic value.
    Clinical Cardiology 04/1996; 19(3):172-8. · 1.83 Impact Factor
  • J D Schlaifer, T D Martin, J A Hill, R A Kerensky
    American Heart Journal 03/1996; 131(2):413-6. · 4.50 Impact Factor